Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06721975 · ClinicalTrials.gov registry record · NA

Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)

A NA study of Nephrolithiasis and Kidney Stones, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06721975 is a NA study of Nephrolithiasis and Kidney Stones that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 121-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06721975, a NA study of Nephrolithiasis and Kidney Stones, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This research study is being conducted to assess the ability and efficiency of two laser systems to break up kidney stones during ureteroscopy with laser lithotripsy for kidney stone treatment.

Interventions

  • DEVICE Thulio pulsed Thulium:YAG (p-Tm:YAG)
  • DEVICE Thulium Laser Fiber (TFL)

Study Locations (1)

California

  • University of California, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-08-01
Est. Completion 2026-12-31
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT06721975

The ClinicalTrials.gov registry entry for NCT06721975 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 121-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (59% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Nephrolithiasis appearing as the primary indexed condition, and to 2 interventions - of which Thulio pulsed Thulium:YAG (p-Tm:YAG) is the first listed.

NCT06721975 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06721975 about?

NCT06721975 is a clinical study titled "Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)". This research study is being conducted to assess the ability and efficiency of two laser systems to break up kidney stones during ureteroscopy with laser lithotripsy for kidney stone treatment.

What is the current status of trial NCT06721975?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-08-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06721975 study?

This clinical trial studies the following conditions: Nephrolithiasis, Kidney Stones.

What interventions are being tested in trial NCT06721975?

The interventions under investigation include: Thulio pulsed Thulium:YAG (p-Tm:YAG) (DEVICE), Thulium Laser Fiber (TFL) (DEVICE).

Who is sponsoring clinical trial NCT06721975?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06721975 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nephrolithiasis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.